Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study.
暂无分享,去创建一个
J. Coebergh | D. Forman | F. Berrino | G. Hédelin | G. Tagliabue | M. Sant | R. Otter | J. Lutz | M. Colonna | T. Aareleid | J. Rachtan | N. Raverdy | M. Artioli | Ivan Plesko I | Maja-Zakelj Primic | G. Hédelin
[1] M. Coleman,et al. Trends in cancer incidence and mortality. , 1993, IARC scientific publications.
[2] Ewout W Steyerberg,et al. Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis. , 2006, European journal of cancer.
[3] M. Marangolo,et al. Germ cell tumours of the testis. , 2005, Critical reviews in oncology/hematology.
[4] H. Adami,et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[5] F Levi,et al. Trends in cancer mortality in the European Union and accession countries, 1980-2000. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] S. Schwartz,et al. Differences in Testis Cancer Survival by Race and Ethnicity: A Population-Based Study, 1973–1999 (United States) , 2004, Cancer Causes & Control.
[7] P. Vasey,et al. Part I: testicular cancer--management of early disease. , 2003, The Lancet. Oncology.
[8] P. Vasey,et al. Part II: testicular cancer--management of advanced disease. , 2003, The Lancet. Oncology.
[9] T. Matsuda,et al. Increasing incidence of testicular cancer worldwide: a review. , 2003, The Journal of urology.
[10] E. Negri,et al. Western and eastern European trends in testicular cancer mortality , 2001, The Lancet.
[11] H. Møller. Trends in incidence of testicular cancer and prostate cancer in Denmark , 2001, Human reproduction.
[12] A. Majeed,et al. Trends in testicular carcinoma in England and Wales, 1971–99 , 2001, BJU international.
[13] L. Collette,et al. Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. , 1999, Journal of the National Cancer Institute.
[14] E. Feuer,et al. Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer. , 1999, Journal of the National Cancer Institute.
[15] G. Hédelin,et al. Improved survival for patients with testicular cancer in Europe since 1978. EUROCARE Working Group. , 1998, European journal of cancer.
[16] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[17] H. Adami,et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. , 1996, Journal of the National Cancer Institute.
[18] D. Forman,et al. Trends in incidence of testicular cancer in boys and adolescent men , 1995, International journal of cancer.
[19] L. Einhorn,et al. Late relapse of testicular cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M. Coleman,et al. Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.
[21] J. Matthews,et al. Time trends in accuracy of classification of testicular tumours, with clinical and epidemiological implications. , 1992, British Journal of Cancer.
[22] A. Brown,et al. Late relapse of testicular cancer. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[24] G. Hédelin,et al. [Survival and prognostic factors of germ cell tumors of the testis in the departments of Bas-Rhin, Isère, and Somme]. , 1999, Annales d'Urologie.
[25] M. Tattersall,et al. Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] P. Boyle,et al. The impact of chemotherapy in germ cell tumours. , 1989, Cancer Surveys.
[27] D. Cox. Regression Models and Life-Tables , 1972 .